Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$3.31 - $18.51 $188 - $1,055
-57 Reduced 0.55%
10,296 $44,000
Q1 2024

May 06, 2024

BUY
$9.77 - $21.47 $101,148 - $222,278
10,353 New
10,353 $152,000
Q3 2022

Nov 03, 2022

BUY
$3.01 - $5.22 $39,151 - $67,896
13,007 New
13,007 $45,000
Q2 2022

Aug 09, 2022

SELL
$2.25 - $9.99 $22,680 - $100,699
-10,080 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$8.12 - $16.9 $81,849 - $170,352
10,080 New
10,080 $89,000
Q1 2018

May 08, 2018

SELL
$18.89 - $32.46 $223,336 - $383,774
-11,823 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$16.19 - $20.3 $191,414 - $240,006
11,823
11,823 $225,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $202M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.